Published in J Natl Cancer Inst on March 01, 1980
Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences. Proc Natl Acad Sci U S A (1981) 9.27
Human papillomavirus 1a complete DNA sequence: a novel type of genome organization among papovaviridae. EMBO J (1982) 4.13
Animal papillomaviruses. Microbiol Rev (1982) 3.19
Comparative analysis of the human type 1a and bovine type 1 papillomavirus genomes. J Virol (1983) 2.69
Laboratory production in vivo of infectious human papillomavirus type 11. J Virol (1987) 2.20
Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx. Proc Natl Acad Sci U S A (1982) 2.11
Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a. J Virol (1987) 2.01
An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels. J Virol (1991) 1.68
Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus. J Clin Pathol (1990) 1.57
Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins. J Virol (1988) 1.51
In vivo transformation of human skin with human papillomavirus type 11 from condylomata acuminata. J Virol (1986) 1.42
Human papillomaviruses: are we ready to type? Clin Microbiol Rev (1989) 1.37
Identification of the human papillomavirus type 6b L1 open reading frame protein in condylomas and corresponding antibodies in human sera. J Virol (1987) 1.26
Presence of human papillomavirus DNA sequences in cervical intraepithelial neoplasia. Br Med J (Clin Res Ed) (1983) 1.25
The prevalence of human papillomavirus antigen in patients with cervical intraepithelial neoplasia. Br J Cancer (1983) 1.22
Human papillomavirus infection of the uterine cervix: histological appearances in 28 cases identified by immunohistochemical techniques. J Clin Pathol (1984) 1.12
Development of type-specific and cross-reactive serological probes for the minor capsid protein of human papillomavirus type 33. J Virol (1993) 1.11
Evaluation of methods for detecting human papillomavirus deoxyribonucleotide sequences in clinical specimens. J Clin Microbiol (1988) 1.00
Characterization of murine polyclonal antisera and monoclonal antibodies generated against intact and denatured human papillomavirus type 1 virions. J Virol (1991) 0.96
Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses. J Virol (1991) 0.96
Human antibodies recognize multiple distinct type-specific and cross-reactive regions of the minor capsid proteins of human papillomavirus types 6 and 11. J Virol (1992) 0.95
Expression of human papillomavirus types 6b and 16 L1 open reading frames in Escherichia coli: detection of a 56,000-dalton polypeptide containing genus-specific (common) antigens. J Virol (1987) 0.92
Frequency and distribution of papillomavirus structural antigens in verrucae, multiple papillomas, and condylomata of the oral cavity. Am J Pathol (1982) 0.90
Demonstration of human papilloma virus type 2 DNA in Bowen's disease. Arch Dermatol Res (1984) 0.83
Serological responses to papillomavirus group-specific antigens in women with neoplasia of the cervix uteri. J Clin Microbiol (1990) 0.80
Human papillomavirus 25-related DNA in solitary keratoacanthoma. Arch Dermatol Res (1986) 0.80
Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis. Clin Microbiol Rev (1991) 0.77
Biologic response modifiers in gynecologic malignancies. Yale J Biol Med (1988) 0.75
Correlation of HPV antigen and type of genital warts with atypia. Genitourin Med (1991) 0.75
The nature of the principal type 1 interferon-producing cells in human blood. Science (1999) 10.90
Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol (1992) 7.14
The pathogenesis of respiratory syncytial virus infection in cotton rats. Am J Pathol (1978) 4.73
Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci U S A (1995) 4.15
Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys J (1991) 4.07
Virus-like particles in phytohemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma. J Natl Cancer Inst (1969) 3.64
Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus. J Virol (1986) 3.64
Animal papillomaviruses. Microbiol Rev (1982) 3.19
Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med (1972) 3.09
Cloning and characterization of the DNA of a new human papillomavirus from a woman with dysplasia of the uterine cervix. J Virol (1986) 2.93
Genetic analysis of the 3' early region transformation and replication functions of bovine papillomavirus type 1. Virology (1986) 2.83
Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci U S A (1996) 2.81
Human papillomavirus DNA in cutaneous primary and metastasized squamous cell carcinomas from patients with epidermodysplasia verruciformis. Proc Natl Acad Sci U S A (1982) 2.74
Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis (2001) 2.51
Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. Br J Pharmacol (1992) 2.50
Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst (1987) 2.45
Interaction of papillomaviruses with the cell surface. J Virol (1994) 2.44
Apparent lack of integration of bovine papillomavirus DNA in virus-induced equine and bovine tumor cells and virus-transformed mouse cells. Virology (1981) 2.44
Design of allele-specific inhibitors to probe protein kinase signaling. Curr Biol (1998) 2.36
Imaging findings of extraventricular neurocytoma: report of 3 cases and review of the literature. AJNR Am J Neuroradiol (2008) 2.30
Papillomavirus capsid binding and uptake by cells from different tissues and species. J Virol (1995) 2.24
Laparoscopic kidney transplantation: an initial experience. Am J Transplant (2011) 2.24
Anogenital warts contain several distinct species of human papillomavirus. J Virol (1980) 2.23
Comparison of direct and indirect solid-phase microradioimmunoassays for the detection of viral antigens and antiviral antibody. Appl Microbiol (1973) 2.23
Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus). J Virol (1993) 2.20
ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat Cell Biol (2001) 2.14
Arterial embolization is a rapid and effective technique for controlling pelvic fracture hemorrhage. J Trauma (1997) 2.12
Identification of a novel human papilloma virus in cutaneous warts of meathandlers. Virology (1981) 2.11
Characterization of normal human exocervical epithelial cells immortalized in vitro by papillomavirus types 16 and 18 DNA. Cancer Res (1988) 2.10
Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer (1997) 2.06
Herpes simplex virus DNA and mRNA sequences in acutely and chronically infected trigeminal ganglia of mice. Virology (1978) 1.99
Unnatural ligands for engineered proteins: new tools for chemical genetics. Annu Rev Biophys Biomol Struct (2000) 1.99
Comparison of neutralization of BPV-1 infection of C127 cells and bovine fetal skin xenografts. Int J Cancer (1991) 1.98
Sexually transmitted papillomaviral infections. I. The anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types. Am J Obstet Gynecol (1987) 1.97
Human papillomaviruses in women with a history of abnormal Papanicolaou smears and in their male partners. Obstet Gynecol (1987) 1.97
Detection of human papillomavirus DNA in anogenital neoplasias. Nature (1982) 1.91
Immunologic identification of papillomavirus antigen in condyloma tissues from the female genital tract. Obstet Gynecol (1980) 1.90
Engineering Src family protein kinases with unnatural nucleotide specificity. Chem Biol (1998) 1.81
Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol (1997) 1.80
Amplification of human papillomavirus DNA sequences by using conserved primers. J Clin Microbiol (1989) 1.80
Rapid micro-radioimmunoassay for the measurement of antiviral antibody. J Immunol (1972) 1.79
Molecular cloning and nucleotide sequence of deer papillomavirus. J Virol (1985) 1.78
Koilocytotic lesions of the cervix. The relationship of mitotic abnormalities to the presence of papillomavirus antigens and nuclear DNA content. Cancer (1984) 1.78
Human exposure to SV40: review and comment. Am J Epidemiol (1976) 1.77
A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys (1997) 1.72
Virus-induced diabetes mellitus. XX. Polyendocrinopathy and autoimmunity. J Exp Med (1981) 1.72
Conserved polynucleotide sequences among the genomes of papillomaviruses. J Virol (1979) 1.70
Demonstration of two distinct classes of bovine papilloma virus. Virology (1978) 1.68
Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology (1994) 1.64
Canine oral papillomavirus genomic sequence: a unique 1.5-kb intervening sequence between the E2 and L2 open reading frames. Virology (1994) 1.63
The value to the anesthesia-surgical care team of the preoperative cardiac consultation. J Cardiothorac Anesth (1989) 1.61
Identification to the species level and differentiation between strains of Aspergillus clinical isolates by automated repetitive-sequence-based PCR. J Clin Microbiol (2004) 1.59
Infant botulism: clinical spectrum and epidemiology. Pediatrics (1980) 1.58
Role of conformational epitopes expressed by human papillomavirus major capsid proteins in the serologic detection of infection and prophylactic vaccination. Gynecol Oncol (1994) 1.58
Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am J Epidemiol (2000) 1.57
Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides. J Infect Dis (1990) 1.57
A new type of papillomavirus associated with cancer of the uterine cervix. Virology (1987) 1.53
Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol (1988) 1.52
Characterization of a major neutralizing epitope on human papillomavirus type 16 L1. J Virol (1999) 1.52
Thrombocytopenia and human immunodeficiency virus in children. Pediatrics (1988) 1.49
Herpes simplex virus in mice: electron microscopy of neural spread. Science (1968) 1.49
The oral management of patients who have received radiotherapy to the head and neck region. Br Dent J (2013) 1.46
Bovine papilloma virus: presence of virus-specific DNA sequences in naturally occurring equine tumors. Proc Natl Acad Sci U S A (1977) 1.45
The role of human papillomaviruses in the pathogenesis and histologic classification of precancerous lesions of the cervix. Hum Pathol (1986) 1.45
Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: a single centre experience. Ann Oncol (2012) 1.44
Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res (1997) 1.42
Analysis of the extractive and hydrolytic behavior of microthane poly(ester-urethane) foam by high pressure liquid chromatography. J Biomed Mater Res (1993) 1.42
Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies. J Natl Cancer Inst (1987) 1.42
Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer (2009) 1.40
Identification of new JNK substrate using ATP pocket mutant JNK and a corresponding ATP analogue. J Biol Chem (2001) 1.39
Human papillomaviruses: their clinical significance in the management of cervical carcinoma. Oncology (Williston Park) (1995) 1.38
Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial. Br J Ophthalmol (2006) 1.37
Quantitation of bovine papilloma viral DNA in viral-induced tumors. J Virol (1976) 1.37
Presence of human papillomavirus infection of the uterine cervix as determined by different detection methods in a low-risk community-based population. Arch Fam Med (1993) 1.36
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1). Br J Pharmacol (2001) 1.35
Factors associated with human papillomavirus infection in women encountered in community-based offices. Arch Fam Med (1993) 1.35
Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease. Vaccine (1989) 1.35
A spectrum of bilateral squamous conjunctival tumors associated with human papillomavirus type 16. Ophthalmology (1991) 1.33
A new approach to the measurement of patients' understanding of what they are told in medical consultations. J Health Soc Behav (1985) 1.32
Isolation and characterization of a novel human papillomavirus type 6 DNA from an invasive vulvar carcinoma. J Virol (1986) 1.32
Immunoperoxidase localization of human papillomavirus in laryngeal papillomas. Intervirology (1980) 1.30
Precipitating antibody to an internal antigen of the C-type virus associated with bovine lymphosarcoma. J Natl Cancer Inst (1972) 1.30
Identification of L2 open reading frame gene products of bovine papillomavirus type 1 using monoclonal antibodies. J Gen Virol (1989) 1.30
Virus-induced diabetes mellitus: reovirus infection of pancreatic beta cells in mice. Science (1978) 1.29
Inter-laboratory variation as an explanation for varying prevalence estimates of human papillomavirus infection. Int J Cancer (1989) 1.27
Immunoperoxidase localization of papillomavirus antigens in cervical dysplasia and vulvar condylomas. Am J Obstet Gynecol (1981) 1.27
Elastosis perforans serpiginosa during penicillamine therapy for Wilson disease. Arch Dermatol (1973) 1.26
Clinical guidelines to diagnose smear-negative pulmonary tuberculosis in Pakistan, a country with low-HIV prevalence. Trop Med Int Health (2006) 1.25
Measures of food insecurity/security. J Nutr Educ (2001) 1.24
Activation defects caused by mutations in Escherichia coli rpoA are promoter specific. J Bacteriol (1992) 1.24